Sunshine Lake Pharma Co., Ltd. (HKG:6887)
49.60
+0.32 (0.65%)
At close: Sep 30, 2025
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 28.60 billion as of September 30, 2025. Its market cap has decreased by -15.50% in one year.
Market Cap
28.60B
Enterprise Value
29.48B
Revenue
3.96B
Ranking
n/a
PE Ratio
22.40
Stock Price
49.60
Market Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 24.86B to 28.60B, an increase of 15.07%. That is a compound annual growth rate of 1.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 28.60B | -10.37% |
Dec 31, 2024 | 31.91B | 0.74% |
Dec 29, 2023 | 31.68B | 46.00% |
Dec 30, 2022 | 21.70B | 6.56% |
Dec 31, 2021 | 20.36B | -30.92% |
Dec 31, 2020 | 29.48B | -60.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 279.26B |
Hansoh Pharmaceutical Group Company | 210.92B |
JD Health International | 206.50B |
Innovent Biologics | 159.71B |
WuXi Biologics | 158.73B |
Sino Biopharmaceutical | 142.12B |
Akeso | 122.24B |
Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |